of pigment synthesis results in a yellow striped band near Molecular and biochemical mechanisms that switch the tip of each hair shaft against a black background. melanocytes between the production of eumelanin or Eumelanin and pheomelanin differ not only in their gross pheomelanin involve the opposing action of two interappearance, but also in their chemical composition and cellular signaling molecules, α-melanocyte-stimulating the ultrastructure of the melanosomes in which they are hormone (MSH) and agouti signal protein (ASP). In synthesized and deposited. Follicular melanocytes of 1-this study, we have characterized the physiological to 2-day-old agouti mice contain ellipsoid and fibrillar effects of ASP on eumelanogenic melanocytes in eumelanosomes, while follicular melanocytes of 4-to culture. Following exposure of black melan-a murine 6-day-old agouti mice contain ovoid and particulate pheomelanocytes to purified recombinant ASP in vitro, pigmelanosomes. Similar changes in pheomelanosomes and mentation was markedly inhibited and the production eumelanosomes have been confirmed in a number of of eumelanosomes was decreased significantly. Melanomouse mutants which produce one or the other type of somes that were produced became pheomelanosomemelanin (Prota et al., 1995) . like in structure, and chemical analysis showed that
Mutations at the agouti locus can cause the production eumelanin production was significantly decreased.
of all yellow or all black hair, depending on whether the Melanocytes treated with ASP also exhibited timemutation leads to overexpression/hyperfunction or nonand dose-dependent decreases in melanogenic gene expression/non-function of ASP, respectively (Perry et al., expression, including those encoding tyrosinase and 1994; Siracusa, 1994; Vrieling et al., 1994) . As examples, tyrosinase-related proteins 1 and 2. Conversely, melanthe dominant lethal yellow mutation (A y ) results in the ocytes exposed to MSH exhibited an increase in tyrosinproduction of completely yellow hairs (Miller et al., 1993 ; ase gene expression and function. Simultaneous Duhl et al., 1994; Michaud et al., 1994) , while the recessaddition of ASP and MSH at approximately equimolar ive non-agouti (a) (Bultman et al., 1994) , lethal non-agouti concentrations produced responses similar to those (a x ) and extreme non-agouti (a e ) elicited by the hormone alone. These results demon- (Hustad et al., 1995) alleles cause the production of strate that eumelanogenic melanocytes can be induced completely black hairs. Consequently, the agouti locus in culture by ASP to exhibit features characteristic of has been recognized to have an important role in regulating pheomelanogenesis in vivo. Our data are consistent the switch between the production of eumelanin or pheowith the hypothesis that the effects of ASP on melanomelanin by melanocytes. cytes are not mediated solely by inhibition of MSH The biochemical action of ASP is controversial and has binding to its receptor, and provide a cell culture model been the source of continuing debate (Conklin and Bourne, to identify novel factors whose presence is required for Jackson, 1993; Yen et al., 1994) . Several studies pheomelanogenesis. (Lu et al., 1994; Blanchard et al., 1995; Willard et al., Keywords: agouti/melanogenesis/pheomelanin/ 1995; Siegrist et al., 1996) have shown that ASP antagonpigmentation/tyrosinase izes the action of α-melanocyte-stimulating hormone (MSH) in activating the melanocyte-specific MSH receptor (MC1-R), which suggests that the effect of the agouti locus on melanocytes is mediated by reduced signaling Introduction through the MC1-R, while its extrapigmentary effects may be mediated by reduced signaling through other The agouti (a) locus is one of Ͼ60 distinct genes that regulate coat color in mice (Silvers, 1979) . The product melanocortin receptors. By contrast, the similarity of ASP to the conotoxins and its ability to elevate intracellular calcium has also been noted (Manne et al., 1995; Willard et al., 1995; Zemel et al., 1995; Perry et al., 1996) , suggesting that some effects of ASP might be mediated by an alteration in calcium channels, a mechanism supported by Hunt and Thody (1995) who found that ASP antagonizes the stimulation of melanogenesis by verapamil (a calcium modulator).
In vivo, we have reported (Kobayashi et al., 1995) that the expression and enzyme activity of tyrosinase was reduced in follicular melanocytes of lethal yellow mice and of 5-to 7-day-old agouti mice but that there was little or no expression or enzyme activity of tyrosinase-related proteins 1 (TRP1) and 2 (TRP2) during pheomelanogenesis. This pattern of expression is consistent with the fact that tyrosinase is required for both types of pigment synthesis, but expression of the two tyrosinase-related proteins (TRP1 and TRP2) is required only for eumelanin synthesis (Tsukamoto et al., 1992; Winder et al., 1994) .
We now describe studies examining the effect(s) of purified recombinant ASP on cultured melanocytes. Following treatment with ASP, eumelanogenic melanocytes in culture exhibit physiologic features characteristic of pheomelanogenesis in vivo, thus providing an in vitro model for characterization of the mechanisms and genes involved in this switch. varying concentrations of ASP for 24 h (Figure 1 ). There were significant dose-dependent decreases in the expression of tyrosinase, TRP1 and TRP2 mRNAs following the MSH receptor. To examine directly the interaction between ASP and MSH in melanocytes, and to characterize treatment with ASP at 10 and 1 nM. However, there was no significant effect on the level of mRNA for MC1-R at further whether ASP might affect MSH signaling via a change in MC1-R receptor level, melan-a melanocytes any ASP concentration tested. The numbers reported below the bands in each of the figures represent the were exposed to 10 nM ASP, 10 nM MSH or both for 5 days ( Figure 2 ). This time was chosen since 4 days of quantitation of those bands by phosphoimager as a percentage of control (means Ϯ SEM in seven independent experitreatment is the standard time to obtain the maximal response to MSH (Jiménez et al., 1988 ; Abdel-Malek ments) following correction for loading against glyceraldehyde-3-phosphate dehydrogenase (GAPDH). et al., 1995) and since maximal responses to 10 nM ASP were also elicited by this time, as found in this study. We The EC 50 for ASP can be calculated at 5 nM based on these results; the EC 50 for MSH is 10 nM (McLane et al., pre-treated the cells with ASP for 1 day prior to the start of MSH treatment in order to maximize the chances of 1987, and our unpublished results).
Results

Fig
To examine the time course response of melanocytes seeing a competitive effect. Treatment with MSH alone produced a 2-fold increase in the level of tyrosinase to ASP, in subsequent experiments we treated the melana cells with 10 nM ASP for up to 11 days (data not mRNA, and lesser increases in TRP1 and TRP2 mRNA, but no significant change in the levels of MC1-R mRNA. shown). Dramatic decreases in the levels of tyrosinase, TRP1 and TRP2 mRNAs were again noted which On the other hand, treatment with ASP alone produced dramatic decreases in the levels of mRNAs for tyrosinase, approached 70-98% inhibition compared with controls following treatment for 2 or more days; maximum effects TRP1 and TRP2, with no significant effect on the level of MC1-R mRNA. At equimolar 10 nM concentrations, were usually noted within 2 days of treatment. Again, no effects were noted on MC1-R mRNA levels during the addition of ASP and then MSH produced a response indistinguishable from that elicited by MSH alone, i.e. 11 day time course of these experiments.
there was little or no antagonism of the MSH effect by ASP under these conditions. Measurements of the Interaction between ASP and MSH As noted in the Introduction, there is evidence using MC1-endogenous MSH concentration in the serum used for these experiments indicate that the residual MSH concen-R-transfected cells that ASP can act as an antagonist of tration in the medium is Ͻ2 pM, several orders of control is virtually undetectable. Exposure to MSH and ASP together produced a pattern that did not differ magnitude less than the EC 50 for stimulation of tyrosinase activity or cAMP accumulation. Thus, these results confirm significantly from MSH alone, results that are consistent with those obtained by Northern blot analysis. the ability of ASP to bring about physiologic changes in the absence of exogenously added MSH, and suggest further that the interaction of ASP and MSH is not Melanogenic enzyme function To examine melanogenic enzyme levels following treatmediated via an alteration in levels of expression of the MSH receptor itself. ment of melanocytes with MSH and/or ASP, we performed Western blotting and enzyme assays under identical conditions. Western blotting ( Figure 4 ) revealed that there were Regulation of melanogenic protein expression by ASP only moderate increases in the amount of tyrosinase, and little or no change in the levels of TRP1 or TRP2, in Steady-state levels of RNA as measured by Northern blot hybridization do not reveal alterations in the expression response to MSH treatment alone. After exposure to ASP alone, there were dramatic and significant decreases in of gene products that might occur due to modulation of protein levels or protein function. To examine the effects the amounts of tyrosinase, TRP1 and TRP2 proteins; note that due to its relatively long half-life, tyrosinase protein of ASP at the translational level, melan-a cells were cultured in the presence or absence of MSH and/or ASP in the untreated control is readily detectable by Western blotting. Enzymatic assays revealed that the catalytic for 5 days, metabolically labeled for 6 h with [ 35 S]methionine and then subjected to immunoprecipitation analysis functions of tyrosinase [i.e. tyrosine hydroxylase, 3,4-dihydroxyphenylalanine (DOPA) oxidase and melanin pro- (Figure 3 ). Synthesis of tyrosinase in response to MSH treatment is significantly increased (Ͼ3-fold), while synduction] were increased dramatically after exposure to MSH, but were decreased to background levels after thesis of TRP1 and TRP2 is also increased, but to a lesser extent. After exposure to ASP alone, synthesis of TRP1 exposure to ASP (Table I) . There was little impact of MSH on the protein levels of TRP1 or TRP2 (or the and TRP2 was significantly suppressed, but we were unable to determine any inhibitory effect of ASP on enzyme activity of the latter, i.e. DOPAchrome tautomerase), whereas ASP clearly diminishes the protein levels tyrosinase synthesis, since, under these labeling conditions, the relatively slow synthesis of tyrosinase in the untreated and catalytic function of both proteins to background Melan-a melanocytes were treated with 10 nM MSH and/or 10 nM ASP for 5 days and then were harvested and solubilized; melanogenic enzyme activities of the extracts were then measured as detailed in Materials and methods. Results for the MSH, ASP and MSH ϩ ASP treatments are reported as n-fold of control values Ϯ SEM (n ജ 4 independent experiments). Control values were: tyrosine hydroxylase, 7.4 Ϯ 0.6; DOPA oxidase, 17.3 Ϯ 5.1; DOPAchrome tautomerase, 148 Ϯ 54; and melanin production, 1.2 Ϯ 0.4 (all in pmol/μg protein/h).
agonism, i.e. a direct effect on the MC1-R itself independent of and opposite to that of MSH. In any of those mechanisms, the effects of ASP are likely to inhibit Jackson, 1993; Suzuki et al., 1996) . To methods.
determine whether ASP could bring about a decrease in cAMP levels in the absence of exogenous MSH, we measured cAMP accumulation in melanocytes exposed levels. Again, simultaneous addition of both ASP and MSH produced a response indistinguishable from that for 40 min to ASP alone or in combination with 10 nM MSH or 20 μg/ml cholera toxin (which increases cAMP elicited by MSH alone. levels by ribosylation of G s protein). As shown in Figure 6 , basal levels of cAMP accumulation in melan-a melanoStructural characteristics After incubation of melan-a cells with 10 nM ASP, the cytes (4.9 Ϯ 0.1 pmol/10 6 cells) were decreased slightly by the addition of ASP at 10 nM (3.9 Ϯ 0.3 pmol/10 6 color of the cell pellets was changed from black to light brown, reflecting the decreased pigmentation evident in cells) or 100 nM (3.4 Ϯ 0.1 pmol/10 6 cells). There was a dramatic (35-fold) stimulation of cAMP following treat-ASP-treated cells at the light and electron microscopic levels ( Figure 5 ). After treatment with MSH, pigmentation ment of melanocytes with MSH, and this stimulation was partially inhibited by a 10-fold excess of ASP (i.e. at of the cells was markedly increased and eumelanosomes were more numerous. However, after exposure to ASP, 100 nM ASP), and was reduced to a 13-fold increase above control. Cholera toxin elicited a 30-fold increase in the number of eumelanosomes in the melan-a melanocytes was decreased significantly, and pheomelanosome-like cAMP accumulation, and this effect was reduced to 20-or 16-fold above control by simultaneous treatment with structures were more predominant. As might be expected from the results presented above, visible pigmentation and 10 or 100 nM ASP, respectively. melanosome structure of melanocytes treated with the combination of ASP and MSH were indistinguishable Discussion from those treated with MSH alone (not shown).
Mammalian hair color is determined primarily by the relative proportions of eumelanin and pheomelanin proChemical analysis Chemical analysis of the types of melanins being produced duced by follicular melanocytes (Ozeki et al., 1995; Prota et al., 1995) . Ratios of eumelanin:pheomelanin of Ͼ1 in response to ASP and/or MSH reveals that while MSH treatment increases the amount of eumelanin production generally result in brown or black hair, the intensity of the color depending upon the total amount of melanins at least 3-fold, it elicited only a slight (~10%) but statistically insignificant decrease in pheomelanin content present. Eumelanin:pheomelanin ratios of Ͻ1 result in the production of yellow or red hair. By those criteria, the (Table II) . Interestingly, however, treatment with ASP led to a dramatic 10-fold reduction in eumelanin content while melanins being produced by melan-a melanocytes under basal conditions, or following treatment with MSH, would the amount of pheomelanin produced increased slightly (~5%, but again not statistically significant). be black or brown (i.e. eumelanic) while those produced following treatment with ASP would be yellow or red (i.e. pheomelanic). This result is quite reasonable since cAMP responses The ability of ASP to inhibit eumelanin synthesis in the melan-a melanocytes were generated from non-agouti black mice and, in the absence of ASP, would be expected absence of exogenous MSH could be mediated by an MC1-R-independent mechanism, by antagonism of to produce eumelanin. Conversely, treatment of melan-a cells with ASP would be expected to induce pheomelanoresidual MSH present in the culture media or by inverse Fig. 5 . Light and electron microscopy of melanocytes treated with MSH and/or ASP. Light (top row, all at initial magnification of 200ϫ) and electron (bottom row, all at initial magnification of 80 000ϫ) microscopy of melan-a melanocytes that were untreated (left), treated with 10 nM MSH (center) or with 10 nM ASP (right) for 5 days. Many melanosomes are found in the untreated control and the MSH-treated cells; at higher magnification, it can be seen that most have the typical elliptical shape with striated filaments that are characteristic of eumelanosomes. Following treatment with ASP for 5 days, the numbers of melanosomes are significantly decreased, and many have pheomelanosome-like ovoid shapes with a more particulate internal matrix.
genesis in vivo, and this occurs in tissue culture as well, MSH is not completely reciprocal to that of ASP. MSH stimulates the expression and function of tyrosinase but suggesting that this in vitro system is an appropriate one mimicking physiological conditions. has little or no effect on TRP1 or TRP2; ASP on the other hand down-regulates all three of these melanogenic Much is known about the biochemistry and cell biology of eumelanogenesis, but a similar level of understanding enzymes. The mechanism by which ASP acts remains controverhas not been achieved for pheomelanogenesis due, in part, to the lack of an appropriate cell culture system. In sial (Conklin and Bourne, 1993; Jackson, 1993; Zemel et al., 1995) . While ASP clearly acts as a competitive vivo, MSH promotes the production of eumelanin, while expression of the agouti gene promotes the production of antagonist of the MC1-R in heterologous cells, this mechanism alone cannot easily explain why ubiquitous pheomelanin. In this study, we now show that purified recombinant ASP added to melan-a melanocytes in culture overexpression of the agouti gene in vivo in lethal yellow mice affects pigmentation and regulation of body weight decreases the expression of several eumelanogenic genes, reduces the production of eumelanin and eumelanosomes differently from recessive yellow mice which have a loss-of-function mutation of the MC1-R. Much of the and increases the production of pheomelanin and pheomelanosome-like structures. These results establish an controversy stems from the lack of a suitable in vitro assay system that accurately reflects the biological activity important tool with which to study pheomelanogenesis and, in addition, suggest that the biochemical action of of the protein in vivo. Our results not only provide such Melanins produced in the samples as described for Table I were subjected to chemical analysis as detailed in Materials and methods; pheomelanin content is estimated by analysis of aminohydroxyphenylalanine (AHP) derivative in the degraded sample, whereas eumelanin content is estimated by quantitation of the pyrrole-2,3,5-tricarboxylic acid (PTCA) derivative. In each experiment, AHP analyses were Fig. 6 . Effects of ASP, MSH and cholera toxin on cAMP performed routinely in duplicate, whereas PTCA analyses could only accumulation. Melan-a melanocytes were cultured to subconfluence, be performed once due to the sample size required. Results for the then incubated for 40 min in the presence of MSH (at 10 nM), cholera MSH, ASP and MSH ϩ ASP treatments are reported as n-fold of toxin (CT, at 20 μg/ml) and/or ASP (at 10 or 100 nM), then assayed control values (averages of two independent measurements). Control for cAMP concentration as detailed in Materials and methods; results values were: pheomelanin content, 169 ng/mg protein; eumelanin are reported as pmol/10 6 cells Ϯ SEM (n ϭ 6). content, 179 ng/mg protein.
decreases the percentage contribution of pheomelanin to the total melanin. ASP, on the other hand, caused a an assay system, but also shed insight into the underlying mechanism, since the ability of purified ASP to induce significant decrease in eumelanin production while at the same time slightly stimulating pheomelanin synthesis, pheomelanogenesis in eumelanic melanocytes demonstrates that ASP alone is sufficient to elicit such changes resulting in a dramatic increase in the percentage contribution of pheomelanin (91%) to the total melanin content. and that cytokines, growth factors, endothelins and other constituents of the epidermis or hair bulbs are not required.
The lack of correlation of pheomelanin production with tyrosinase mRNA synthesis or enzyme function argues This study now confirms the antagonism of ASP on MSHinduced stimulation of cAMP in melanocytes, but also strongly that an as yet undiscovered enzyme or regulatory point is at least partly responsible for pheomelanin content. shows that ASP has physiologic effect(s) in the absence of exogenous MSH.
Why eumelanogenic melanocytes, when introduced into culture, produce significant levels of pheomelanin in the Two of the genes we have examined, TRP1 and TRP2, encode enzymes that catalyze specific distal steps in the absence of exogenously added ASP, is not known at this time, although it has been noted previously (Sato et al. , eumelanogenic pathway, and we have shown previously that expression of these genes ceases during pheomelano1985a; Hunt et al., 1995) . The latter report showed that human melanocytes introduced into culture produced siggenesis in vivo. The enzymatic activity of the third member of the TRP family, tyrosinase, is required for both types nificant levels of pheomelanin that did not correlate with the racial origin of those melanocytes. It is possible that of pigment synthesis; tyrosinase is also down-regulated during pheomelanogenesis in vivo, though not to the same nutrient concentrations in the media that are not present in the epidermal microenvironment play a role in this extent as TRP1 and TRP2. The changes in gene expression we have described here for melan-a cells treated with ASP determination, but further study will be necessary to resolve this point. are similar to those that occur during pheomelanogenesis in vivo, although in vitro ASP has a comparable downSeveral hypotheses have been put forward to explain the mechanism of ASP action, including competitive regulatory effect on tyrosinase, TRP1 and TRP2. This discrepancy may be caused by intrinsic differences antagonism for MSH binding, binding to an as yet unidentified 'agouti receptor' or modulation of calcium flux. between melan-a cells, which were derived from neonatal epidermis, and hair follicle melanocytes. Epidermal and Distinguishing between these alternatives is difficult since virtually all of the effects of ASP, including those reported hair follicle melanocytes arise from the same pool of precursor melanoblasts, but could later acquire changes here, can be reversed by the addition of exogenous MSH. Our results demonstrate that ASP antagonizes MC1-R in cell surface receptors or intracellular signaling that affect their pheomelanogenic potential. In addition, extrinsic signaling, but effects of ASP treatment can be observed in the absence of exogenous MSH. Our findings are differences could help to explain why pheomelanin is produced within and not between hair follicles, and unlikely to be explained by the presence of residual MSH in the culture medium since the concentration of treatment of melan-a cells with paracrine factors unique to the follicular microenvironment may identify molecules endogenous MSH in the medium is 1000-fold below the EC 50 for MSH, but could be accounted for by inverse that function in addition to and/or downstream of ASP that promote pheomelanogenesis.
agonism, particularly if the MC1-R has a significant degree of constitutive activity. The hypothesis that the action of The results of chemical analyses of melanins produced in the presence or absence of MSH and/or ASP in vitro ASP is independent of MSH but not of the MC1-R could be addressed by studies of normal melanocytes cultured clearly demonstrate the effect of MSH in stimulating eumelanin synthesis with a negligible effect on pheomelfrom non-mutant animals and those that carry the recessive yellow (Mc1r e ) mutation. The stage is now set for critical anin production. MSH thus elicits a marked increase in the percentage of eumelanin produced and thus dramatically studies to characterize the regulation of gene expression 0.1 M sodium cacodylate buffer, pH 7.3. The samples were stored in phosphate-buffered saline (PBS) containing 2% sucrose at 4°C, then processed with graded alcohols and embedded in epoxy resin in the usual manner. Thin sections were stained with uranyl acetate and lead citrate, viewed and photographed with a Zeiss EM10 electron microscope, as previously detailed (Prota et al., 1995) .
RNA isolation and Northern blotting
Total RNA was extracted from cells using an RNeasy total RNA isolation kit (QIAGEN, Catsworth, CA), following the manufacturer's instructions. Twenty μg of total RNA were denatured, electrophoresed through 1.0% agarose gels and transferred overnight at 23°C to SureBlot nylon hybridization membranes (Oncor, Gaithersburg, MD) in the standard manner. Filters were pre-hybridized for 3 h at 45°C with Hybrisol I solution (Oncor), and then hybridized with 32 P-labeled probes. A 2.0 kb EcoRI fragment of TYRS-J, a 1.7 kb HindIII fragment of pMT4, a 1.75 kb EcoRI fragment of TRP2a and a 2.1 kb BamHI-SalI fragment of A26 were used to detect tyrosinase, TRP1, TRP2 and MC1-R mRNAs, respectively. TYRS-J was obtained from Drs Hiroaki Yamamoto and Takuji Takeuchi, Sendai, Japan; pMT4 was obtained from Dr Shigeki Shibahara, Sendai, Japan; TRP2a was obtained from Dr Ian Jackson, Edinburgh, UK; A26 was obtained from Dr Roger Cone, Oregon. A commercially available cDNA probe specific for GAPDH was used to standardize RNA loading on the blots. The cDNA probes were labeled using random primer extension and heated to 100°C for 10 min, then cooled on ice for 10 min prior to adding to the hybridization solution.
Hybridization was performed with the radiolabeled probes in Hybrisol I (3ϫ10 7 c.p.m./10 ml) overnight at 45°C with gentle shaking. Following incubation, the blots were washed for 10 min at 23°C with 2ϫ SSC/ 10% SDS, for 10 min with 0.2ϫ SSC/0.5% SDS and finally for 10 min with 0.1ϫ SSC/0.1% SDS. Blots were exposed in phosphoroimager cassettes at 23°C for 1 h and the densities of the bands were scanned using ImageQuant software. The percentage control for each probe was Fig. 7 . Purity of recombinant ASP used in these studies. ASP was corrected for initial loading using comparison with the GAPDH standard. expressed in a baculovirus system, purified and separated by SDS Residual probes were then removed by repeated washings for 15 min at electrophoresis on 15% acrylamide gels as detailed in Materials and 100°C in 0.1ϫ SSC/0.1% SDS in 10 mM Tris, pH 7.0 until no remaining methods. The position of molecular weight markers (M) is shown, as probe could be detected. is a buffer control (-); 1 μg of ASP was used on the Coomassie Blue-stained gel (left) while 0.1 μg of ASP was used in the Metabolic labeling and immunoprecipitation silver-stained gel (right).
These techniques were performed as previously reported (Tsukamoto et al., 1992; Aroca et al., 1993) . Briefly, subconfluent cells growing in and cellular signaling mechanisms triggered by MSH 10 cm diameter dishes were pre-incubated for 1 h at 37°C in methionineand ASP that modulate the pheomelanogenic switch in free medium, and then radiolabeled for 6 h with 0.4 mCi/flask of melanocytes.
[ 35 S]methionine. The cells were then harvested and solubilized for 1 h at 4°C with NP-40/SDS buffer (1% NP-40, 0.01% SDS, 0.1 M TrisHCl, pH 7.2, 100 μM phenylmethylsulfonyl fluoride, 1 μg/ml aprotinin).
Materials and methods
The cell lysates were then centrifuged for 15 min at 14 000 g at 4°C, and the supernatants were pre-treated overnight at 4°C with normal Cells and cell culture conditions rabbit serum and GammaBind G Sepharose (Pharmacia/LKB, Piscataway, The melan-a melanocyte line, derived from C57Bl non-agouti black NJ) to reduce background. Then 5ϫ10 6 c.p.m. of each pre-absorbed mice, was a kind gift from Dr Dorothy Bennett, London, and was supernatant were incubated with 10 μl of rabbit antibodies generated cultured in Dulbecco's minimal essential medium with additives as against peptides corresponding to the unique carboxyl sequences of the described by Bennett et al. (1987) . Cells were usually seeded at 1.5ϫ10 6 three melanogenic proteins studied; they are termed αPEP1, αPEP7 and cells per 15 cm diameter dish. For 24 h experiments, we added ASP αPEP8, which recognize TRP1, tyrosinase and TRP2, respectively and/or MSH immediately, while for the 5 day experiments, we added (Tsukamoto et al., 1992) . Following incubation at 37°C for 1 h, 50 μl ASP immediately, and MSH was added starting on the next day. The of GammaBind G Sepharose was mixed in each tube for 20 min at concentrations of ASP and MSH used ranged from 0.01 to 10 nM, as 23°C, and the immune complexes were washed four times with NP-40/ detailed in the figure and table legends. The cells were cultured routinely SDS buffer at 23°C and then denatured in SDS sample buffer by heating at 37°C in a humidified incubator with 5% CO 2 , and all media were to 100°C for 3 min. Specifically bound proteins were then analyzed by changed daily. Cells were harvested by brief treatment with trypsin/ SDS-PAGE and visualized by autoradiography. EDTA, and used for subculture, or were processed for RNA, protein or enzyme analysis, as detailed below.
Western immunoblotting analysis Cells in tissue culture were harvested and solubilized for 1 h at 4°C Agouti signal protein with NP-40/SDS buffer, then centrifuged at 14 000 g for 15 min at 4°C, Recombinant mouse ASP was generated and purified using a baculovirus and the supernatants were recovered. Proteins from the NP-40/SDSexpression system as described in Ollmann et al. (in preparation) . The solubilized cells were separated on 7.5% SDS gels, and then transferred ASP used for the experiments is ജ90% pure, as estimated by analysis electrophoretically to polyvinylidene difluoride membranes (Immobilonof gels stained with Coomassie Blue or silver stain (Figure 7) , and P, Millipore Corp., Bedford, MA). Following blocking overnight at 23°C inhibits activation of the MC1-R with a K i of 2.2ϫ10 -10 M. At 37°C, in 3% bovine serum albumin in TBS/Tween (0.1% Tween-20 in Tris-ASP retains activity for Ͼ48 h in water or tissue culture media. The buffered saline), the blots were incubated with primary antibodies (at experiment described in Figure 2 has also been repeated with an ASP 1:1000 dilution in TBS/Tween). Following four washes in TBS/Tween preparation ജ99% pure with virtually identical results.
to reduce non-specific binding, subsequent visualization of specific antibodies bound was carried out with Enhanced ChemiLuminescence Electron microscopy (Amersham Corp., Arlington Heights, IL) according to the manufacturer's Cells were harvested, centrifuged for 5 min at 14 000 g at 4°C, and fixed for 2 h at 23°C in 2% glutaraldehyde-2% paraformaldehyde in instructions.
